Treatment
Treatment A clinical trials
We’re tracking 8,307 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT07405476RecruitingPhase 2
Zanidatamab before surgery for HER2 positive colon or rectal cancer
This trial tests if the drug zanidatamab, given before surgery, can help treat colon or rectal cancer that has a specific marker called HER2. The goal is to see if this approach can shrink tumors and improve outcomes for people whose cancer has not spread to other parts of the body.
Atlanta, GeorgiaAges 18 years+ - NCT07405229RecruitingPhase 4
Medical treatment for idiopathic ventricular fibrillation patients
This study tests medical treatments for people who survived a cardiac arrest with a specific heart rhythm problem called idiopathic ventricular fibrillation. If your cardiac arrest was likely from a heart issue but not from clogged arteries, you might help find better treatments.
Copenhagen, Dr.Ages 18 years+ - NCT07400692Recruiting
Surgery vs. Non-surgery for Broken Elbow in Older Adults
This study compares two ways to treat a certain type of broken elbow in adults over 65 who are not extremely active or frail. It tests if using a metal plate to fix the bone during surgery leads to better arm function and recovery than treating the injury without surgery.
LuganoAges 65 years+ - NCT06435663Recruiting
ultramicro-flow technique for focused ultrasound treatment of uterine tumors
This study tests a new imaging tool (ultramicro-flow technique) to help doctors treat uterine fibroids or adenomyosis with focused ultrasound without surgery. The goal is to make the treatment safer and more accurate, especially for tumors deep inside the uterus.
Yiwu, ZhejiangAges 18–50 - NCT07389876Recruiting
Second-line treatment for advanced stomach cancer with nab-paclitaxel
This trial tests a new chemotherapy combination for patients with advanced stomach cancer that has worsened after initial treatment. It aims to find a better second-line option using a drug called nab-paclitaxel.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06720168Recruiting
Erythritol air polisher for dental black stain treatment
This trial tests if a special cleaning tool using erythritol can safely remove black stains from teeth caused by bacteria. It may help people with at least two stained teeth who haven't used antibiotics recently or have certain health issues.
Alfara del Patriarca, ValenciaAges Any age - NCT06779435Recruiting
Tucidinostat-based treatment for untreated DLBCL
This trial tests a treatment plan that includes the drug tucidinostat for people who have not yet been treated for a type of lymphoma called DLBCL. It focuses on patients whose cancer cells have certain features (double expression of MYC and BCL2, or certain gene changes) that might affect how well standard treatments work.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07384273Recruiting
Online therapy for postpartum depression symptoms
This trial tests an internet-based therapy program (iCARE) to help new mothers manage symptoms of postpartum depression. It may be a good fit if you gave birth within the last 6 months and have been feeling down or depressed.
OdenseAges 18 years+ - NCT06255535Recruiting
Brain-guided brain stimulation for autism
This study tests if a type of brain stimulation (rTMS) guided by brain scans can improve thinking and behavior in people with autism who also have intellectual disability. It aims to help with social communication and daily function.
Fuzhou, FujianAges 6–30 - NCT05390268Recruiting
Mobile app behavioral therapy for youth with tic disorders
This trial tests whether a mobile app can help children and teens reduce tic symptoms using behavioral treatment strategies. It may help if your tics are affecting your daily life and you have not had very recent tic-specific behavioral training.
Aarhus N, RisskovAges 9–17 - NCT06839898Recruiting
Study of two implantable astigmatism-correcting lenses
This study tests two types of implantable lenses that correct astigmatism (blurry vision from an irregularly shaped cornea). You keep your own natural lens, and the new lens is placed in front of it—no laser or lens removal needed. The goal is to see which lens works better and is safer.
Münster, North Rhine-WestphaliaAges 21 years+ - NCT05199909RecruitingPhase 2
Testing zanubrutinib for antiphospholipid syndrome with low platelets
This Phase 2 study tests zanubrutinib, a medicine for the immune system, to treat antiphospholipid syndrome when it causes very low platelet counts. It looks at safety and whether it can improve blood clotting problems and low platelets when prior steroid treatment didn’t work well.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT05214391RecruitingPhase 2
Zanubrutinib for chronic immune low platelets after prior treatments
This Phase 2 study looks at zanubrutinib, a new medication, in people with immune thrombocytopenia (ITP) whose low platelet count has lasted more than 3 months and has not responded to prior steroid and other treatments. It may help raise platelets and reduce bleeding risk when other therapies have not worked.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06281327RecruitingPhase 2
Avatrombopag for children with ITP switching from eltrombopag
This trial tests a new platelet-raising medicine, avatrombopag, in children with ITP who have already tried eltrombopag. It aims to see if switching to avatrombopag can safely increase platelet counts and reduce bleeding.
TianjinAges 6–18 - NCT06094881RecruitingPhase 2
Obinutuzumab for teens with immune thrombocytopenia
This trial tests a drug called obinutuzumab for teens aged 12–18 with persistent or chronic immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The study aims to see if obinutuzumab can safely raise platelet counts in those who haven't responded well to steroids or other treatments.
TianjinAges 12–18 - NCT07374094Recruiting
Understanding C. difficile infection and treatment effects
This study is tracking patients with a confirmed C. difficile infection to understand how the body responds and how treatments work. You may be asked to do follow-up visits for up to 5 years.
UmeåAges 18 years+ - NCT07375576Recruiting
Comparing partial nerve removal to root canal for severe tooth pain
This study compares two ways to treat severe tooth pain from advanced decay: a partial nerve removal (pulpotomy) versus a full root canal treatment. It aims to find which approach works better for saving the tooth.
Hatay, AntakyaAges 18–45 - NCT07376486Recruiting
Early treatment for type 2 diabetes using a new duodenal procedure
This study tests a new procedure called pulsENDO, which is done in the first part of the small intestine (the duodenum) to help treat type 2 diabetes. It may be an option for people who were recently diagnosed and have good blood sugar control with little or no diabetes medication.
ShatinAges 18–60 - NCT06683391Recruiting
Improving Low Blood Sugar Guidelines for Type 1 Diabetes
This study is looking for adults with type 1 diabetes to help improve guidelines for preventing and treating low blood sugar (hypoglycemia). The goal is to make recommendations that are more practical and safer for people like you.
Montreal, QuebecAges 18 years+ - NCT07369102RecruitingPhase 4
Esketamine with or without talk therapy for tough depression
This trial tests if adding a type of talk therapy called integration therapy helps esketamine work better for people with depression that hasn't improved with other treatments. You'll receive esketamine, and some people also get guided sessions to reflect on their experiences.
San JuanAges 21–65 - NCT07369180Enrolling by invitation
TMS for treatment-resistant depression in adults
This study tests a new type of transcranial magnetic stimulation (TMS) for adults whose depression hasn't gotten better with medication. It compares the real treatment to a sham (inactive) version to see how well it works.
Campbell, CaliforniaAges 22–85 - NCT07359183Recruiting
Long-term follow-up of kids who had oral immunotherapy for allergies
This study checks on children and young people 5 to 15 years after they finished an 18-month oral immunotherapy treatment for peanut, egg, or milk allergy. It helps researchers understand how their allergies and health are doing over the long term.
Parkville, VictoriaAges Any age - NCT07354048Recruiting
Thyroid health and its effect on liver function
This study looks at how thyroid problems (both overactive and underactive) may affect liver function tests. It aims to help researchers understand the link between thyroid and liver health.
SohagAges 20–60 - NCT07357493Recruiting
Studying a new surgery for hand bone fractures
This trial tests a new way to fix certain broken hand bones (metacarpals) using a metal plate. It compares this method to other treatments to see which works better for healing and recovery.
Stockholm, Stockholm CountyAges 18 years+
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,307 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.